Section Arrow
MAZE.NASDAQ
- Maze Therapeutics Inc
Quotes are at least 15-min delayed:2025/11/16 15:48 EST
Regular Hours
Last
 32.53
+0.69 (+2.17%)
Day High 
33.76 
Prev. Close
31.84 
1-M High
34.29 
Volume 
912.66K 
Bid
28
Ask
51.77
Day Low
31.625 
Open
31.99 
1-M Low
26.9578 
Market Cap 
1.53B 
Currency USD 
P/E 191.34 
%Yield -- 
10-SMA 31.42 
20-SMA 30.91 
50-SMA 27.2 
52-W High 34.29 
52-W Low 6.71 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.56/-3.00
Enterprise Value
1.55B
Balance Sheet
Book Value Per Share
7.89
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
167.50M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ASBPAspire Biopharma Holdings Inc.0.1063+0.0011+1.05%-- 
CYPHCypherpunk Technologies Inc.2.75+0.99+56.25%-- 
IVVDInvivyd2.35+0.58+32.77%-- 
APLTApplied Therapeutics0.2183-0.0517-19.15%-- 
RXRXRecursion Pharmaceuticals4.14-0.19-4.39%-- 
Quotes are at least 15-min delayed:2025/11/16 15:48 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.